Evidence map›Paper›PMID 30948779›Full record

ArticleScientific reports2019

Lp-PLA

Shahab Fatemi, Anders Gottsäter, Moncef Zarrouk, Gunnar Engström, Olle Melander, Margaretha Persson, Stefan Acosta

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Next-generation molecular tools in veterinary parasitology: advances, challenges, and perspectives in the diagnosis of emerging parasites.Revista brasileira de parasitologia veterinaria = Brazilian journal of veterinary parasitology : Orgao Oficial do Colegio Brasileiro de Parasitologia Veterinaria · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shahab FatemiDepartment of Clinical Sciences, Malmö, Lund University, Malmö, Sweden.
Anders GottsäterDepartment of Clinical Sciences, Malmö, Lund University, Malmö, Sweden.
Moncef ZarroukDepartment of Clinical Sciences, Malmö, Lund University, Malmö, Sweden.
Gunnar EngströmDepartment of Clinical Sciences, Malmö, Lund University, Malmö, Sweden.
Olle MelanderDepartment of Clinical Sciences, Malmö, Lund University, Malmö, Sweden.
Margaretha PerssonDepartment of Clinical Sciences, Malmö, Lund University, Malmö, Sweden.
Stefan AcostaDepartment of Clinical Sciences, Malmö, Lund University, Malmö, Sweden. Stefan.acosta@med.lu.se.ORCID http://orcid.org/0000-0002-3225-0798
Lund University · SEMalmö University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long follow up is needed in prospective cohort study evaluation of plasma biomarkers for incident peripheral arterial disease (PAD) Middle-aged PAD-free individuals from the cardiovascular cohort of the Malmö Diet and Cancer study (n = 5550; 1991-94) were followed prospectively for a median time of 23.4 years. The plasma biomarkers lipoprotein-associated phospholipase A2 (Lp-PLA

Indexed as

1-Alkyl-2-acetylglycerophosphocholine EsteraseAdultAgedAtherosclerosisBiomarkersCohort StudiesC-Reactive ProteinFemaleHumansHypertensionIncidenceLongitudinal StudiesMaleMiddle AgedPeripheral Arterial DiseaseProportional Hazards Models1-Alkyl-2-acetylglycerophosphocholine EsteraseBiomarkersC-Reactive ProteinPLA2G7 protein, human

Identifiers

PMID30948779
PMCPMC6449361
OpenAlexW2928726625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.